Micah Sturgeon

Micah Sturgeon serves as a procurement specialist responsible for managing complex acquisitions in the biomedical and healthcare technology sectors. Their role centers on ensuring timely and compliant procurement of critical medical devices, diagnostic tools, and life sciences infrastructure, aligning with federal requirements for quality, safety, and operational readiness. Sturgeon handles a diverse portfolio of contract actions under FAR Part 12 and Part 13, primarily executing competitive solicitations for high-precision instrumentation and regulated medical supplies. Their work directly supports mission-critical healthcare delivery systems, requiring deep familiarity with FDA-regulated products and quality management standards. While specific contractor names are not currently available, Sturgeon maintains a consistent engagement pattern with manufacturers and distributors specializing in electromedical equipment, surgical supplies, and in-vitro diagnostic systems. Their procurement approach emphasizes technical evaluation, performance-based requirements, and vendor compliance with ISO 13485 and 21 CFR Part 820. Relationships are typically structured around long-term blanket purchase agreements and indefinite-delivery/indefinite-quantity contracts to ensure supply chain resilience and rapid response capabilities. Sturgeon demonstrates a strong commitment to small business participation, with 25% of acquisitions designated as total small business set-asides under FAR 19.5. While the majority of awards remain open to all competitors, the consistent use of small business set-asides reflects a deliberate strategy to foster innovation and expand vendor diversity within the medical technology supply base. No evidence suggests reliance on other socioeconomic categories such as 8(a), HUBZone, or SDVOSB, indicating a focused preference for general small business eligibility. The procurement portfolio is heavily concentrated in NAICS 339112 (surgical and medical instrument manufacturing) and 334510 (electromedical apparatus), with significant activity in blood and organ banking (621991) and in-vitro diagnostic substance manufacturing (325413). This specialization underscores deep expertise in regulated medical devices, laboratory diagnostics, and sterile supply chains, requiring technical knowledge of biocompatibility, sterilization validation, and clinical performance standards.